Condensed Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
|
| Income Statement [Abstract] | ||||
| Research and development | $ 915,363 | $ 273,038 | $ 1,843,397 | $ 463,306 |
| General and administrative | 964,281 | 279,093 | 2,662,293 | 665,742 |
| Total operating expenses | 1,879,644 | 552,131 | 4,505,690 | 1,129,048 |
| Loss from operations | (1,879,644) | (552,131) | (4,505,690) | (1,129,048) |
| Other income (expenses), net | 3,153 | (3,701) | 2,813 | (11,767) |
| Net loss | (1,876,491) | (555,832) | (4,502,877) | (1,140,815) |
| Deemed dividends | (8,208,393) | (8,208,393) | ||
| Net loss attributable to common stockholders | $ (1,876,491) | $ (8,764,225) | $ (4,502,877) | $ (9,349,208) |
| Weighted average common shares outstanding, basic and diluted | 23,344,567 | 12,982,500 | 23,344,567 | 12,656,310 |
| Net loss per share, basic and diluted | $ (0.08) | $ (0.68) | $ (0.19) | $ (0.74) |
| X | ||||||||||
- Definition Net loss per share, basic and diluted. No definition available.
|
| X | ||||||||||
- Definition Weighted average common shares outstanding, basic and diluted. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|